Latest filing published 27 May 2024 for SBO AG, €13k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brigitte Ederer (board member) discloses dealings in 2 companies, chiefly Marinomed Biotech AG and SBO AG. The record holds 5 filings, for trades running from 15 December 2021 to 23 May 2024.
On the market, this insider has only ever bought: 5 purchases, €624k in total. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: 1 purchase and no sales on the market.
Half of the purchases are above €212k and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 27 May 2024 with an open-market purchase (€13k) in SBO AG. Typically, a trade is published a median of 4 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by FMA (OeKB OAM). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations